论文部分内容阅读
髋、膝关节置换术患者合并心血管疾病时是发生动静脉血栓栓塞的高危因素,部分合并心血管疾病患者已用华法林,术中出血风险增加.为提高合并心血管疾病的髋、膝关节置换术患者的围术期安全性,多学科专家对临床上髋、膝关节置换术患者合并心血管疾病的桥接抗凝和术前、术后的抗凝处理达成共识,供临床医师参考.“,”Cardiovascular diseases are the high risk factor of artery and vein thrombosis for patients who are going to re-ceive the total hip arthroplasty (THA) and total knee arthroplasty (TKA). Some patients with cardiovascular diseases al-ready receive drugs such as warfarin to treat their diseases before the surgery. These drugs will increase intraoperative blood loss. In order to guarantee the safety of patients with cardiovascular diseases, experts from different disciplines make this consensus on bridging anticoagulation and anticoagulation program in the perioperative period of THA and TKA. And we hope this consensus will help clinicians.